Theravance Biopharma (STU:0TB) Cash from Discontinued Operating Activities : €0.00 Mil (TTM As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is Theravance Biopharma Cash from Discontinued Operating Activities?

Cash from Discontinued Operating Activities is net cash from all of the entity's discontinued operating activities.

Theravance Biopharma's Cash from Discontinued Operating Activities for the three months ended in Mar. 2025 was €0.00 Mil. It means Theravance Biopharma received €0.00 Mil from discontinued investing activities. Theravance Biopharma's Cash from Discontinued Operating Activities for the trailing twelve months (TTM) ended in Mar. 2025 was €0.00 Mil.

Theravance Biopharma Cash from Discontinued Operating Activities Historical Data

The historical data trend for Theravance Biopharma's Cash from Discontinued Operating Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theravance Biopharma Cash from Discontinued Operating Activities Chart

Theravance Biopharma Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Cash from Discontinued Operating Activities

Get a 7-Day Free Trial

10.15

24.71

-174.23

Theravance Biopharma Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Cash from Discontinued Operating Activities	Get a 7-Day Free Trial															-	-	-	-	-

Theravance Biopharma Cash from Discontinued Operating Activities Calculation

Cash from Discontinued Operating Activities is net cash from all of the entity's discontinued operating activities.

Cash from Discontinued Operating Activities for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

Theravance Biopharma Cash from Discontinued Operating Activities Related Terms

Thank you for viewing the detailed overview of Theravance Biopharma's Cash from Discontinued Operating Activities provided by GuruFocus.com. Please click on the following links to see related term pages.

Theravance Biopharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theravance Biopharma Inc (STU:0TB) » Definitions » Cash from Discontinued Operating Activities

Comparable Companies

Traded in Other Exchanges

TBPH:USA 0TB:Germany

Address

901 Gateway Boulevard, South San Francisco, CA, USA, 94080

Website

https://www.theravance.com

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Theravance Biopharma Headlines

No Headlines